1. Academic drug discovery: the chemistry challenges of target choice and screening library selection Christopher A. Lipinski Scientific Advisor, Melior Discovery [email_address]…

Slide 1Structural Bioinformatics in Drug Discovery Melissa Passino Slide 2 Structural Bioinformatics What is SBI? “Structural bioinformatics is a subset of bioinformatics…

1. The TDR Targets DatabasePrioritizing potential drug targetsin complete genomes 2. Prioritizing targets in whole genomes • TDR Targets facilitates the prioritization…

1. Is Brugia malayi’s cofactor-independentphosphoglycerate mutase (iPGM) druggable?Gregory J. Crowther1, Michael L. Booker2,Min He3, Ting Li3, Sylvine Raverdy4,Jacopo…

1. 2. Why Space?National Lab Pathfinder Strategy:Applying knowledge from microgravity research to develop medicines in space to save lives on Earth.Advantages…

Slide 1 Life Sciences Life Sciences Richard M. Eglen ELRIG, Manchester, UK September 7-8, 2011 High throughput screening and assay development – fit for purpose? Slide…

Slide 1 20/03/2008 Dept.of Pharmaceutics 1 Genomics & Proteomics Based Drug DISCOVERY Dr. Basavaraj K. Nanjwade M.Pharm., Ph. D Associate Professor Department of Pharmaceutics…

Slide 1 Who gets IBD and Why? Dr Miles Parkes, Cambridge Dr Hannah Gordon, London RSM and CCUK® 2015 Slide 2 Introduction Who? Epidemiology Why? Heritability – twin and…

Drug Design - A multiple task Drug design may be approached in various ways, but basic concepts about drugs, receptors, and drug–receptor interactions are of highest importance.…

PowerPoint Presentation Molecular Biology of Cancer 1 CANCER TAKES TIME CANCER IS A DISEASE OF GENETIC MUTATIONS ACCUMULATION OF MANY MUTATIONS CAUSES CANCER YOU MUST REMEMBER…